ACROBiosystems

ACROBiosystems

Address
1 Innovation Way
Newark
DE, 19711
United States
Phone: +1 800 810 0816
Visit Website Request Information/Quote Download PDF Copy

ACROBiosystems is a cornerstone enterprise of the pharmaceutical and biotechnology industries. Their mission is to help overcome challenges with innovative tools and solutions from discovery to the clinic. They supply life science tools designed to be used in discovery research and scalable to the clinical phase and beyond. By consistently adapting to new regulatory challenges and guidelines, ACROBiosystems delivers solutions, whether it comes through recombinant proteins, antibodies, assay kits, GMP-grade reagents, or custom services. ACROBiosystems empower scientists and engineers dedicated towards innovation to simplify and accelerate the development of new, better, and more affordable medicine.

Products & Solutions

Products, Articles & More

ACROBiosystems Aneuro Partners with Diagnostic Biochips to Accelerate Neuroscience Drug Discovery

ACROBiosystems Aneuro Partners with Diagnostic Biochips to Accelerate Neuroscience Drug Discovery
Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research
ACROBiosystems and the Fight Against COVID-19

ACROBiosystems and the Fight Against COVID-19
AviTag™: GMP-grade biotinylated human CD5 protein

AviTag™: GMP-grade biotinylated human CD5 protein
CelThera™ GMP T Cell Expansion Medium (Phenol Red-free): A serum-free culture medium

CelThera™ GMP T Cell Expansion Medium (Phenol Red-free): A serum-free culture medium
GENIUS™ nuclease

GENIUS™ nuclease
GENIUS™ nuclease (salt active)

GENIUS™ nuclease (salt active)
GMP ActiveMax® human T cell magnetic beads

GMP ActiveMax® human T cell magnetic beads
GMP compliant SCF protein

GMP compliant SCF protein
GMP compliant TNF-alpha proteins

GMP compliant TNF-alpha proteins
GMP GM-CSF Proteins

GMP GM-CSF Proteins
GMP-certified recombinant human IL-18 protein

GMP-certified recombinant human IL-18 protein
GMP-compliant human IL-21 protein

GMP-compliant human IL-21 protein
GMP-grade biotinylated human DLL4 protein

GMP-grade biotinylated human DLL4 protein
GMP-grade GENPower™ NLS-Cas9 nuclease

GMP-grade GENPower™ NLS-Cas9 nuclease
GMP-grade human activin A / INHBA protein for therapeutic use

GMP-grade human activin A / INHBA protein for therapeutic use
GMP-grade human BMP-4 / BMP2B protein

GMP-grade human BMP-4 / BMP2B protein
GMP-grade human DLL4 protein

GMP-grade human DLL4 protein
GMP-grade human FGF basic protein

GMP-grade human FGF basic protein
GMP-grade human FGF-8b protein

GMP-grade human FGF-8b protein
GMP-grade human Flt-3 ligand protein

GMP-grade human Flt-3 ligand protein
GMP-grade human IFN-gamma protein

GMP-grade human IFN-gamma protein
GMP-grade human IL-1 beta protein

GMP-grade human IL-1 beta protein
GMP-grade monoclonal anti-human CD28 antibody

GMP-grade monoclonal anti-human CD28 antibody
GMP-grade monoclonal anti-human CD3 antibody

GMP-grade monoclonal anti-human CD3 antibody
GMP-grade recombinant human fibronectin fragment

GMP-grade recombinant human fibronectin fragment
High-purity GMP-grade human IL-3 protein

High-purity GMP-grade human IL-3 protein
High-quality GMP human IL-12 protein

High-quality GMP human IL-12 protein
Human IL-15 protein with GMP certification

Human IL-15 protein with GMP certification
Human IL-4 protein (GMP-grade)

Human IL-4 protein (GMP-grade)
Human IL-7 proteins

Human IL-7 proteins
Human M-CSF protein

Human M-CSF protein
Human VCAM-1 proteins

Human VCAM-1 proteins
Laminin 511 protein

Laminin 511 protein
Laminin 521 protein

Laminin 521 protein
Liquid GMP-grade human IL-2 protein

Liquid GMP-grade human IL-2 protein
PDGF-BB protein

PDGF-BB protein
Recombinant GMP-grade human IL-2 protein

Recombinant GMP-grade human IL-2 protein
Recombinant Human 4-1BB Ligand Protein with Fc Tag (GMP Grade)

Recombinant Human 4-1BB Ligand Protein with Fc Tag (GMP Grade)
Recombinant human IL-6 protein (GMP-certified)

Recombinant human IL-6 protein (GMP-certified)
Seamless GMP VEGF165 protein

Seamless GMP VEGF165 protein
Support human T cell culture with the CelThera™ GMP T Cell Expansion Medium

Support human T cell culture with the CelThera™ GMP T Cell Expansion Medium
TGF-Beta 1/TGFB1 protein

TGF-Beta 1/TGFB1 protein
Therapeutic-grade GMP human IL-10 protein

Therapeutic-grade GMP human IL-10 protein
Thrombopoietin protein

Thrombopoietin protein
A Cost-Effective, Efficient and Convenient Bead-Based Phagocytosis Assay

A Cost-Effective, Efficient and Convenient Bead-Based Phagocytosis Assay
A critical target for chronic gastrointestinal disorders: Integrin 4/7 (LPAM-1)

A critical target for chronic gastrointestinal disorders: Integrin 4/7 (LPAM-1)
Accelerated immunotherapeutic development through improved transmembrane protein manufacturing

Accelerated immunotherapeutic development through improved transmembrane protein manufacturing
Accelerating COVID-19 Neutralizing Antibody Screening

Accelerating COVID-19 Neutralizing Antibody Screening
Activin R for weight loss

Activin R for weight loss
Advancing immune cell profiling technology

Advancing immune cell profiling technology
Advancing organoid research using highly validated growth factors and cytokines

Advancing organoid research using highly validated growth factors and cytokines
An Emerging Immune Checkpoint Target: TIGIT

An Emerging Immune Checkpoint Target: TIGIT
Antibody drug development: Targeting CD20 and CD3

Antibody drug development: Targeting CD20 and CD3
Anti-CD20 mAbs profiling

Anti-CD20 mAbs profiling
Anti-Idiotypic Antibodies Overview

Anti-Idiotypic Antibodies Overview
Anti-idiotypic antibodies: How are they used in drug development?

Anti-idiotypic antibodies: How are they used in drug development?
Anti-tumor treatment with a Nanobody

Anti-tumor treatment with a Nanobody
Are peptide drugs the only answer to the hundred-billion-level weight loss market?

Are peptide drugs the only answer to the hundred-billion-level weight loss market?
Are Respiratory Syncytial Virus (RSV) vaccines on the way?

Are Respiratory Syncytial Virus (RSV) vaccines on the way?
Are Serological Tests Unreliable? Or the Protein Reagents?

Are Serological Tests Unreliable? Or the Protein Reagents?
Available SARS-CoV-2 Antigen Proteins for Testing

Available SARS-CoV-2 Antigen Proteins for Testing
Brain organoids for advancing neurological research

Brain organoids for advancing neurological research
Can 'No-needle' COVID-19 protection be achieved with inhaled aerosol vaccines?

Can 'No-needle' COVID-19 protection be achieved with inhaled aerosol vaccines?
Capabilities of a Recombinant Spike Protein Trimer

Capabilities of a Recombinant Spike Protein Trimer
CAR-T Therapy: Combating Cytokine Release Syndrome

CAR-T Therapy: Combating Cytokine Release Syndrome
CAR-T therapy: Grading and mitigating Cytokine Release Syndrome (CRS)

CAR-T therapy: Grading and mitigating Cytokine Release Syndrome (CRS)
CAR-T Therapy: Syndrome Released by Cytokine

CAR-T Therapy: Syndrome Released by Cytokine
Cell and gene therapy (CGT) and global supply chain security

Cell and gene therapy (CGT) and global supply chain security
Cell culture grade magnetic beads

Cell culture grade magnetic beads
Cell therapies and immune system rebalancing

Cell therapies and immune system rebalancing
Cell-Based Assays to Fight COVID-19

Cell-Based Assays to Fight COVID-19
Characterization and Identification of Neutralizing Antibodies Against COVID-19

Characterization and Identification of Neutralizing Antibodies Against COVID-19
Charting recent advances in PSMA-targeted therapy for prostate cancer

Charting recent advances in PSMA-targeted therapy for prostate cancer
Chimeric Antigen Receptor Expression Evaluation

Chimeric Antigen Receptor Expression Evaluation
Combating cervical cancer with HPV vaccine research

Combating cervical cancer with HPV vaccine research
Combating Parkinson’s disease, the second most common neurodegenerative disease

Combating Parkinson’s disease, the second most common neurodegenerative disease
Controlling a Tumor Microenvironment

Controlling a Tumor Microenvironment
COVID-19 and the Role of Neutralizing Antibodies (NAbs)

COVID-19 and the Role of Neutralizing Antibodies (NAbs)
COVID-19 Neutralizing Antibody Screening Tools

COVID-19 Neutralizing Antibody Screening Tools
COVID-19 vaccines: An overview

COVID-19 vaccines: An overview
COVID-19 Vaccines: Safety and Efficacy Evaluation

COVID-19 Vaccines: Safety and Efficacy Evaluation
COVID-19: Can Aerosolized Nanobodies be a Gamechanger?

COVID-19: Can Aerosolized Nanobodies be a Gamechanger?
COVID-19: Omicron recombinants, where could the next strain emerge?

COVID-19: Omicron recombinants, where could the next strain emerge?
Culturing organoids for utilization in preclinical modeling of human disease

Culturing organoids for utilization in preclinical modeling of human disease
Culturing T-cells efficiently and effectively

Culturing T-cells efficiently and effectively
Cytokine Release Syndrome (CRS): How susceptible are CAR-NK therapies

Cytokine Release Syndrome (CRS): How susceptible are CAR-NK therapies
D614G Mutation of COVID-19: What Does it Mean?

D614G Mutation of COVID-19: What Does it Mean?
Demonstrating how to enhance antitumor activity and overcome T cell exhaustion

Demonstrating how to enhance antitumor activity and overcome T cell exhaustion
Development of New Tools to Fight SARS-CoV-2

Development of New Tools to Fight SARS-CoV-2
Developments in the targeting of Claudin 6 in Antibody and CAR-T cell therapies

Developments in the targeting of Claudin 6 in Antibody and CAR-T cell therapies
Discovering a potent neutralizing antibody (NAb) for future COVID-19 VOCs and mutants

Discovering a potent neutralizing antibody (NAb) for future COVID-19 VOCs and mutants
Discussing major hypotheses of Alzheimer’s disease

Discussing major hypotheses of Alzheimer’s disease
Dual targeting of both LILRB and HLA-G for an effective anti-cancer immunotherapy combination

Dual targeting of both LILRB and HLA-G for an effective anti-cancer immunotherapy combination
Ensuring the quality control of bispecific antibody drugs in development

Ensuring the quality control of bispecific antibody drugs in development
Evaluating CAR Expression for CAR-T Cell Therapy

Evaluating CAR Expression for CAR-T Cell Therapy
Evaluating CD19 CAR expression levels in clinical trial and quality checks

Evaluating CD19 CAR expression levels in clinical trial and quality checks
Evaluating influenza vaccine ingredients

Evaluating influenza vaccine ingredients
Evaluating transgene delivery in human organoid models to select AAV capsids

Evaluating transgene delivery in human organoid models to select AAV capsids
Examining ACROBiosystem's role in cell and gene therapy (CGT) development

Examining ACROBiosystem's role in cell and gene therapy (CGT) development
Examining SSTR2 as a potential therapeutic target for cancer therapy

Examining SSTR2 as a potential therapeutic target for cancer therapy
Examining the potential of CXCR4 and CCR5 as therapeutic targets for cancer and HIV therapy

Examining the potential of CXCR4 and CCR5 as therapeutic targets for cancer and HIV therapy
Exploring CD63 as a target in the diagnostics and treatment of cancer

Exploring CD63 as a target in the diagnostics and treatment of cancer
Exploring solutions for AAV R&D

Exploring solutions for AAV R&D
Exploring the associations between cytokines and autoimmune diseases

Exploring the associations between cytokines and autoimmune diseases
Exploring the emerging applications of target-specific pre-coupled magnetic beads

Exploring the emerging applications of target-specific pre-coupled magnetic beads
Facilitating drug development using full-length transmembrane protein platforms

Facilitating drug development using full-length transmembrane protein platforms
Facilitating innovative drug development with FLAG Claudin family proteins

Facilitating innovative drug development with FLAG Claudin family proteins
Fc receptors: A classification and overview

Fc receptors: A classification and overview
FcRn and its role as a therapeutic target

FcRn and its role as a therapeutic target
Feeder-cell alternatives for large-cell iPSC manufacturing

Feeder-cell alternatives for large-cell iPSC manufacturing
FGL1 Protein Characterization for Cancer Detection

FGL1 Protein Characterization for Cancer Detection
Fighting against cancer with innovative immune checkpoint therapy

Fighting against cancer with innovative immune checkpoint therapy
Finding new immunotherapy targets - Immune system agonists

Finding new immunotherapy targets - Immune system agonists
G-Protein coupled receptors (GPCRs) and their role in targeted drug development

G-Protein coupled receptors (GPCRs) and their role in targeted drug development
Gram-level supply and production of Omicron antigens and antibodies

Gram-level supply and production of Omicron antigens and antibodies
High-Affinity CD19 for CAR-T Cell Therapy

High-Affinity CD19 for CAR-T Cell Therapy
High-throughput antibody screening for a thriving antibody drug industry

High-throughput antibody screening for a thriving antibody drug industry
How are external contaminants controlled during cell and gene therapy materials production?

How are external contaminants controlled during cell and gene therapy materials production?
How can we ensure the safety and efficacy of biopharmaceuticals?

How can we ensure the safety and efficacy of biopharmaceuticals?
How do cell therapy manufacturers ensure quality in critical raw materials?

How do cell therapy manufacturers ensure quality in critical raw materials?
How Tecelra® approval is transforming TCR-T cell therapy

How Tecelra® approval is transforming TCR-T cell therapy
How to select a development strategy for anti-idiotypic antibodies

How to select a development strategy for anti-idiotypic antibodies
Human CD20 Full-Length Proteins

Human CD20 Full-Length Proteins
Human organoids for AAV capsid selection

Human organoids for AAV capsid selection
Identification of a Bispecific Antibody with Bioactivity Analysis

Identification of a Bispecific Antibody with Bioactivity Analysis
Identifying and Studying COVID-19 Spike Protein Mutations on B.1.617

Identifying and Studying COVID-19 Spike Protein Mutations on B.1.617
Identifying the structure of RSV pre- and post-fusion proteins

Identifying the structure of RSV pre- and post-fusion proteins
IFN-γ: Targeted antibodies for detection and monitoring

IFN-γ: Targeted antibodies for detection and monitoring
Immune Checkpoint Protein Testing

Immune Checkpoint Protein Testing
Important targets for small cell lung cancer treatment: DLL3 & Notch

Important targets for small cell lung cancer treatment: DLL3 & Notch
In vitro functional assays to augment immunotherapy research

In vitro functional assays to augment immunotherapy research
In vitro methods for TL1A screening

In vitro methods for TL1A screening
Inactivated Virus Samples to Verify COVID-19 Anti-Nucleocapsid Antibodies

Inactivated Virus Samples to Verify COVID-19 Anti-Nucleocapsid Antibodies
Infectivity of SARS-CoV-2 with Spike Protein Mutations

Infectivity of SARS-CoV-2 with Spike Protein Mutations
Integrin-Associated Protein CD47 Leukocyte Surface Antigen

Integrin-Associated Protein CD47 Leukocyte Surface Antigen
Interleukin-4 receptor (IL-4R): A drug target with massive potential

Interleukin-4 receptor (IL-4R): A drug target with massive potential
Investigating SARS-CoV-2 Therapeutic Structure with SEC-MALS

Investigating SARS-CoV-2 Therapeutic Structure with SEC-MALS
Investigating the CMC production process of adoptive T-cell therapy

Investigating the CMC production process of adoptive T-cell therapy
Is a Successful COVID-19 Candidate Vaccine to Market within One Year Feasible?

Is a Successful COVID-19 Candidate Vaccine to Market within One Year Feasible?
Isolating SARS-CoV-2 Antibodies for Future Treatments

Isolating SARS-CoV-2 Antibodies for Future Treatments
Key Features of SPR-Verified Fc Receptor Proteins

Key Features of SPR-Verified Fc Receptor Proteins
Living with COVID-19: A reflection on the pandemic

Living with COVID-19: A reflection on the pandemic
Making antibody-drug conjugate development more rapid through site-specific conjugation

Making antibody-drug conjugate development more rapid through site-specific conjugation
Manufacturing cell therapeutics through GMP-grade protein services

Manufacturing cell therapeutics through GMP-grade protein services
Mass Spectrometry Analysis of Heavy-Labeled Proteins

Mass Spectrometry Analysis of Heavy-Labeled Proteins
Measuring Drug Concentration in Serum - Evaluating Assay Designs

Measuring Drug Concentration in Serum - Evaluating Assay Designs
Multiple Sclerosis: Examining the pathology, etiology, and potential therapeutic drugs

Multiple Sclerosis: Examining the pathology, etiology, and potential therapeutic drugs
N Protein in COVID-19 Diagnostic Kits

N Protein in COVID-19 Diagnostic Kits
N Protein Variants and Their Importance in Antibody Test and Design

N Protein Variants and Their Importance in Antibody Test and Design
N Terminal Domain of S1 Protein: Potential Target for Coronavirus

N Terminal Domain of S1 Protein: Potential Target for Coronavirus
Omicron-specific antibodies help with Omicron-based and polyvalent vaccine R&D

Omicron-specific antibodies help with Omicron-based and polyvalent vaccine R&D
Optimizing antibody development through recombinant antibody services

Optimizing antibody development through recombinant antibody services
Overview of ELISA Testing for COVID-19 Antibodies

Overview of ELISA Testing for COVID-19 Antibodies
Potentially breaking the COVID-19 stalemate with variant booster, bivalent or polyvalent vaccines

Potentially breaking the COVID-19 stalemate with variant booster, bivalent or polyvalent vaccines
Pre-formed fibrils (PFFs) and the modelling of neurodegenerative diseases

Pre-formed fibrils (PFFs) and the modelling of neurodegenerative diseases
Prevention is the best medicine: Untangling viruses and vaccines

Prevention is the best medicine: Untangling viruses and vaccines
Process of Antibody Drug Development with SPR&BLI Analytical Service

Process of Antibody Drug Development with SPR&BLI Analytical Service
Recombinant Protein Receptor Tyrosine Kinases ROR1 and ROR2

Recombinant Protein Receptor Tyrosine Kinases ROR1 and ROR2
Results of Pfizer COVID-19 mRNA Vaccine Phase 1/2 Study

Results of Pfizer COVID-19 mRNA Vaccine Phase 1/2 Study
Reviewing immunological breast cancer targets

Reviewing immunological breast cancer targets
SARS-CoV-2 Infection: Do You Know About the Antibody-Dependent Enhancement (ADE)?

SARS-CoV-2 Infection: Do You Know About the Antibody-Dependent Enhancement (ADE)?
SARS-CoV-2 S Protein Glycosylation

SARS-CoV-2 S Protein Glycosylation
SARS-CoV-2 Spike D614G Mutant is More Transmissible than Other Mutants

SARS-CoV-2 Spike D614G Mutant is More Transmissible than Other Mutants
Scalable manufacturing of iPSC-derived cell therapies using GMP-grade laminin

Scalable manufacturing of iPSC-derived cell therapies using GMP-grade laminin
Sensitive and Accurate Diagnostic Tests of COVID-19 with High-Quality SARS-CoV-2 Proteins

Sensitive and Accurate Diagnostic Tests of COVID-19 with High-Quality SARS-CoV-2 Proteins
Sensitive CAR expression detection with flow cytometry

Sensitive CAR expression detection with flow cytometry
Solid tumors: The next wall to overcome for cell therapies

Solid tumors: The next wall to overcome for cell therapies
Structural characterization of lgC variants

Structural characterization of lgC variants
Supporting Therapeutic Antibody Development with Fc Receptor Affinity Testing

Supporting Therapeutic Antibody Development with Fc Receptor Affinity Testing
T cell Immunoreceptor with lg and ITIM Domains Signaling Axis

T cell Immunoreceptor with lg and ITIM Domains Signaling Axis
Targeting CD38/CD3 in the immunotherapy of Multiple Myeloma

Targeting CD38/CD3 in the immunotherapy of Multiple Myeloma
Targeting DLL-3 for a variety of potential lung cancer therapies

Targeting DLL-3 for a variety of potential lung cancer therapies
Targeting Interleukin-6 (IL-6) to alleviate immune and inflammatory system dysfunction

Targeting Interleukin-6 (IL-6) to alleviate immune and inflammatory system dysfunction
Targeting Multiple Myeloma Using B-Cell Maturation Antigens

Targeting Multiple Myeloma Using B-Cell Maturation Antigens
Targeting the emerging Omicron variant BA.2.75 with antigen products

Targeting the emerging Omicron variant BA.2.75 with antigen products
Targets for Biosimilar Drugs

Targets for Biosimilar Drugs
The B.1.617 Variant of SARS-CoV-2 is Likely Behind the COVID-19 Surge in India

The B.1.617 Variant of SARS-CoV-2 is Likely Behind the COVID-19 Surge in India
The complement cascade and its therapeutic potential in COVID-19, cancer and general inflammation

The complement cascade and its therapeutic potential in COVID-19, cancer and general inflammation
The evolution of STEAP1 targeted therapy

The evolution of STEAP1 targeted therapy
The Future of targeted cancer immunotherapy using universal CAR-NK cell therapy

The Future of targeted cancer immunotherapy using universal CAR-NK cell therapy
The Immune Checkpoint Pathway - PD-1 Recombinant Protein Collection

The Immune Checkpoint Pathway - PD-1 Recombinant Protein Collection
The pathology and epidemiology of Amyotrophic Lateral Sclerosis (ALS)

The pathology and epidemiology of Amyotrophic Lateral Sclerosis (ALS)
The role of cytokines as key drivers of autoimmune pathogenesis

The role of cytokines as key drivers of autoimmune pathogenesis
The role of human erythropoietin in LNP-mediated mRNA drug discovery

The role of human erythropoietin in LNP-mediated mRNA drug discovery
The tumor microenvironment: A summary of components and important pathways

The tumor microenvironment: A summary of components and important pathways
The two strategies for FcRn mediated therapeutic mechanisms

The two strategies for FcRn mediated therapeutic mechanisms
Therapeutic Antibody Quantification in Serum Samples Using ELISA Assay Kits

Therapeutic Antibody Quantification in Serum Samples Using ELISA Assay Kits
Therapeutic strategies for brain tumors: An overview

Therapeutic strategies for brain tumors: An overview
Two anti-TNFα antibodies shine for therapeutic drugs, vaccines and diagnostics

Two anti-TNFα antibodies shine for therapeutic drugs, vaccines and diagnostics
Understanding STAT3, the intersection of many carcinogenic signaling pathways

Understanding STAT3, the intersection of many carcinogenic signaling pathways
Understanding tau PFFs and alpha-synuclein PFFs

Understanding tau PFFs and alpha-synuclein PFFs
Understanding the role of tumor microenvironment in cancer metastasis

Understanding the role of tumor microenvironment in cancer metastasis
Using a matrigengel matrix for cell culturing, disease modeling and more

Using a matrigengel matrix for cell culturing, disease modeling and more
Using Animal Models to Defeat COVID-19

Using Animal Models to Defeat COVID-19
Using combination therapy to overcome insufficient responses in programmed death ligand-1 (PD-1) inhibitors

Using combination therapy to overcome insufficient responses in programmed death ligand-1 (PD-1) inhibitors
Using organoid culturing for preclinical human disease models

Using organoid culturing for preclinical human disease models
Utilizing growth factors and cytokines to boost dendritic cell proliferation and differentiation

Utilizing growth factors and cytokines to boost dendritic cell proliferation and differentiation
Utilizing interleukin 2 for immune cell activation and expansion

Utilizing interleukin 2 for immune cell activation and expansion
VEGF: A consistent target for antitumor therapy

VEGF: A consistent target for antitumor therapy
Verifying S Protein in a Trimeric Form

Verifying S Protein in a Trimeric Form
What are the applications of neuronal antibodies in neuroscience?

What are the applications of neuronal antibodies in neuroscience?
What are the clinical applications and biological functions of distinct CD3 subunits?

What are the clinical applications and biological functions of distinct CD3 subunits?
What are the US and EU compliance requirements for GMP ancillary materials in CGT manufacturing?

What are the US and EU compliance requirements for GMP ancillary materials in CGT manufacturing?
What is the association between cytokines and autoimmune diseases?

What is the association between cytokines and autoimmune diseases?
What is the full potential of iPSC-derived allogeneic cell therapy?

What is the full potential of iPSC-derived allogeneic cell therapy?
What We Know About SARS-CoV-2 One Year Later: Part 1

What We Know About SARS-CoV-2 One Year Later: Part 1
What We Know About SARS-CoV-2 One Year Later: Part 2

What We Know About SARS-CoV-2 One Year Later: Part 2
What We Know About SARS-CoV-2 One Year Later: Part 3

What We Know About SARS-CoV-2 One Year Later: Part 3
What We Know About SARS-CoV-2 One Year Later: Part 4

What We Know About SARS-CoV-2 One Year Later: Part 4
Addressing challenges in antibody-drug conjugate development

Addressing challenges in antibody-drug conjugate development
Building the perfect antibody-based therapeutic from selection to engineering and manufacturing

Building the perfect antibody-based therapeutic from selection to engineering and manufacturing
Challenges and strategies in method development for vaccine efficacy evaluation

Challenges and strategies in method development for vaccine efficacy evaluation
Inflammatory Bowel Disease - The latest progress of biologics drug development and market trends

Inflammatory Bowel Disease - The latest progress of biologics drug development and market trends
Aneuro: Advancing Neuroscience Research

Aneuro: Advancing Neuroscience Research
Aneuro: An Overview of Neuroscience Research

Aneuro: An Overview of Neuroscience Research
Aneuro: Solutions for in vivo Electrophysiology Recordings

Aneuro: Solutions for in vivo Electrophysiology Recordings
FLAG: Multi-pass Transmembrane Proteins and Technology Platforms eBook

FLAG: Multi-pass Transmembrane Proteins and Technology Platforms eBook
AAV capsid selection for transgene delivery in organoid models

AAV capsid selection for transgene delivery in organoid models
Accelerating novel antibody drug development

Accelerating novel antibody drug development
Design and development of target proteins in drug discovery

Design and development of target proteins in drug discovery
E.coli DNA testing to support CGT development

E.coli DNA testing to support CGT development
Evaluating Fc gamma receptors

Evaluating Fc gamma receptors
Exploring cerebral and cardiac organoids

Exploring cerebral and cardiac organoids
How to maximize ELISA practices

How to maximize ELISA practices
How to scale induced pluripotent stem cell differentiation into natural killer cells

How to scale induced pluripotent stem cell differentiation into natural killer cells
iPSC-derived organoids for organ-specific disease modeling

iPSC-derived organoids for organ-specific disease modeling
Raw material considerations for CGT

Raw material considerations for CGT
Scalable differentiation of induced pluripotent stem cells into cytotoxic natural killer cells

Scalable differentiation of induced pluripotent stem cells into cytotoxic natural killer cells
Scalable protocols for T cell activation

Scalable protocols for T cell activation
Using cerebral organoids as neuroinflammation models

Using cerebral organoids as neuroinflammation models

More Content

Archived ACROBiosystems News

Trending Stories

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback